Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities (Q28570196)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Molecular cloning and functional characterization of the rat analogue of human decay-accelerating factor (CD55)

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Homologous species restriction in lysis of erythrocytes by terminal complement proteins

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Complement C3 convertase: Cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Molecular and functional analysis of mouse decay accelerating factor (CD55)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Decay accelerating factor regulates complement activation on glomerular epithelial cells

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Purification of 1F5 antigen that prevents complement attack on homologous cell membranes.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species.

3 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00066.X

Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2000.00066.X

Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327033

Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies

27 November 2018

1 reference

12 December 2020

Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor

1 reference

12 December 2020

Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function

1 reference

12 December 2020

Functional differences among multiple isoforms of guinea pig decay-accelerating factor

1 reference

12 December 2020

Xenogeneic transplantation

1 reference

12 December 2020

Characterization in vitro and in vivo of the pig analogue of human CD59 using new monoclonal antibodies

1 reference

12 December 2020

Evidence for restriction of the ability of complement to lyse homologous erythrocytes

1 reference

12 December 2020

Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9

1 reference

12 December 2020

Homologous species restriction of the complement-mediated killing of nucleated cells

1 reference

12 December 2020

CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis

1 reference

12 December 2020

Relative roles of decay‐accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement‐mediated lysis

1 reference

12 December 2020